How Humans Evolved a Starch-Digesting Superpower Long Before Farming

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
cover

Table of Contents

If you’ve ever felt a rush of energy after consuming a thick slice of bread or a roasted yam, you should be thankful for an amazing genetic mutation that occurred in our ancestors hundreds of thousands of years ago. Recent research has uncovered how humans evolved to become better starch digesters and how such an evolutionary trait, as it would turn out, actually predates the birth of agriculture by a long shot.

Indeed, two landmark studies-one in Nature and the other in Science-shed light on how the gene responsible for digestion of starch, AMY1, has evolved. This gene helps in the production of the enzyme amylase, which acts on starch in our mouth and breaks it down to sugars. Investigations not only delve into when this gene first duplicated but also reveal how the rise of agriculture has massively influenced its evolution.

 

The Starch-Digesting Gene: AMY1

The gene responsible for salivary amylase, AMY1, begins the digestion of starch by producing amylase in the saliva. Modern humans have multiple copies of this gene, and populations with high-starch diets-whether from grains or tubers-tend to have even more copies. This allows them to extract even more energy out of starchy foods; this trait has doubtlessly played a key role in survival within a population.

Until now, however, the origins of this gene duplication, and why AMY1 has become so prone to multiple copies, had remained unresolved. The following recent studies add a great deal to the previous knowledge about the timing of duplication and its genetic mechanism, therefore unraveling the evolutionary journey of starch-digestive capabilities in humans.

 

The Evolution of AMY1: Conflicting Timelines

While the two studies agree on the general outlines of how AMY1 evolved, they disagree on precisely when the gene first duplicated. Using one of the studies, from Peter Sudmant of the University of California, Berkeley, the gene duplication is pegged at roughly 279,000 years ago, long before agriculture took root. The other, led by Charles Lee from the Jackson Laboratory and Omer Gokcumen from the University at Buffalo, offers an even earlier timeline: perhaps the gene duplicated as long ago as 800,000 years.

That’s a striking difference, yet it does nothing to contradict the central findings: both studies confirm that agriculture’s rise did indeed affect the number of AMY1 copies found in modern-day humans.

 

Agriculture and the Surge of AMY1

Agriculture, which began around 12,000 years ago, turned wheat, yams, and rice into food staples. As these starch-rich crops became more common, people who carried extra copies of the AMY1 gene were better adapted to digesting starch and absorbing nutrition from them. In essence, the shift toward agricultural diets triggered an explosive proliferation of AMY1 gene copies in successive generations, both teams report.

The Sudmant-led study examined the genomes of 519 ancient Eurasians to go back 12,000 years. The team believed that an average of four to over seven copies of AMY1 per person increased about 5,000 years ago when agriculture spread across Europe and Asia. The increased copy number of AMY1 was a striking example of natural selection for the ability to convert starch into energy more efficiently, which helped early individuals survive and reproduce in agrarian societies.

 

Neanderthals and Denisovans: Did They Have AMY1 Duplications?

The question for the research was whether human relatives such as Neanderthals and Denisovans also carried multiple copies of the AMY1 gene. As these new studies explain, the answer is complicated.

However, Sudmant’s team found no evidence of duplicated copies of the gene in the genomes of three Neanderthals and one Denisovan. By contrast, the work of Lee and Gokcumen indicates another scenario: duplications of the gene AMY1 in some Neanderthals and Denisovans. This would suggest either that the gene duplications occurred far earlier than previously thought, or that those ancient relatives had acquired the gene copies through interbreeding with modern humans.

Whatever the exact timing, it is clear that AMY1 duplications have been a part of the human genome for a long period and such gene copies most probably played an important role in enabling early humans and their relatives to adapt to different dietary environments.

 

Why is AMY1 So Prone to Duplication?

One of the big contributions of the new studies is to explain how easily the AMY1 gene duplicates. The work by Lee and Gokcumen shows that once a specific version of the gene-a “three-copy haplotype”-arose, it served as a template for further duplications. Because of the way gene copies were arranged on the chromosomes, a process called crossing over was possible, in which DNA from two copies could mingle and copy itself.

This process explains how some populations came to have considerably more copies of the gene, while others suffered deletions. “The moment we have the three-copy haplotype, it’s the steppingstone for the evolution of this locus-we can either go up by two copies or we can go down by two,” says Charikleia Karageorgiou, a postdoctoral researcher and co-author on the study.

 

Implications for Evolutionary Biology

The revelation of duplication mechanisms of the AMY1 gene provides a wider understanding of how structural variations in the genome contribute to human evolution. “These findings are very exciting,” says Diyendo Massilani, a geneticist at Yale University, who adds that it could spur further research into how gene copy number variations have driven human adaptation. This research could also yield some clues toward understanding other genetic conditions related to gene copy number, such as Huntington’s disease.

This ability to digest starch more effectively has clearly been a valuable trait for humans over the millennia, helping to fuel the rise of agriculture and to support growing populations. And as researchers continue to unravel the many complexities in our evolutionary history, it would seem genes like AMY1 have played a very important role in shaping who we are today.

 

Conclusion

The evolution of the AMY1 gene and this starch digestion superpower give an exciting glimpse into the dynamics of human adaptability. With the timeline of duplication of AMY1 still under debate, one thing is for sure: such a genetic trait has played an important role in human survival and dietary evolution. From the first mutations that allowed early humans to digest starch a little better, through the agricultural revolution that multiplied AMY1 gene copies manyfold, this genetic story is one of resilience and adaptation.

As researchers continue to learn more about the subject, we piece together a complex puzzle of just how our ancestors evolved to develop the tools needed for them to thrive on a diet based on starchy foods, a capability that shaped human history.

At AHB Lab, we’re committed to keeping you informed on these crucial developments and their impact on our industry. Stay tuned for more insights as the election progresses!

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

你的消炎藥只是在「關掉煙霧探測器」?從源頭阻斷慢性發炎的胜肽科學

為什麼你的疲倦與疼痛總是反覆發作? 你是不是經常覺得關節痠痛、莫名疲倦,或者有各種過敏和腸胃問題,卻始終找不出確切原因 ? 在現代高壓與快節奏的生活中,許多人都在尋求這些亞健康狀態的解藥。事實上,現代人90%的慢性病,其實都來自同一個源頭:你體內有一把撲不滅的「無名火」,醫學上稱之為「慢性發炎」 。 當面臨這些不適,多數人的第一反應是服用非類固醇消炎藥(NSAIDs)或類固醇。然而,這些傳統藥物往往只能提供短暫的舒緩,一旦停藥,症狀便會捲土重來。這不禁讓我們反思:我們是否只在處理表面症狀,而忽略了真正的問題根源?   傳統消炎藥的盲點與機制 要理解傳統藥物的局限性,我們必須先了解發炎的運作機制。當身體受到外界刺激時,免疫系統中的「巨噬細胞」會釋放 TNF-α 和 IL-1β 等發炎細胞因子 。這本是身體為了防禦而響起的警報器,但當免疫系統失衡,這些發炎因子便會失控形成「細胞因子風暴」,開始無差別攻擊正常細胞、黏膜和關節,甚至破壞 DNA 。 傳統的西藥如 NSAIDs 是如何運作的呢?它們主要的作用機制是抑制下游的 COX-1 或 COX-2 酵素 。 為了讓大家更直觀地理解,我們可以比較一下這兩種機制的差異:

Read More
公司最新訊息

止痛藥的隱形代價:淨火肽如何透過「8小時降解」機制重塑無毒抗炎新標準?

引言 在現代高壓的生活節奏中,面對關節痠痛或慢性疲勞,多數人的第一反應往往是去藥房購買非類固醇消炎止痛藥,或是服用醫生開立的類固醇 。當藥效發揮,疼痛的警報聲停止,我們便誤以為身體恢復了健康 。 然而,你吞下的那顆止痛藥,在讓你感覺不到痛之後,究竟去了哪裡? 這是一個多數消費者忽略,而品牌研發端必須正視的痛點。傳統藥物在體內的作用機制,實際上只是粗暴地抑制了下游的 COX 酵素 。這就像是一群莽漢直接砸爛了火災警報器,卻對真正引發火災的源頭無能為力 。更嚴重的是,這些無法被身體完全辨識與利用的化學合成物,在完成掩蓋任務後並不會憑空消失,而是轉化為化學廢棄物 。 這些殘留物迫使肝臟超負荷運作以進行代謝,同時也讓腎臟拼命處理排毒 。由於 COX 酵素被過度抑制,人體保護胃壁的機制隨之停擺,最終導致腸胃黏膜逐漸受到破壞 。這不是真正的治療,而是一場用內臟健康換取短暫不痛的恐怖交易 。身為保健或保養品牌的決策者,我們必須思考:除了這種「拆東牆補西牆」的化學療法,我們能否為市場提供一種更安全、無毒的解答?   核心機制深潛 為了解決傳統消炎藥物的瓶頸,富比積生物科技(AHB Lab)突破傳統藥理學限制,研發出名為「淨火肽 Healtide®」的第三代生物合成定序胜肽 。這項技術透過「生物黑客」的思維,重新定義了抗炎機制的標準。   1.

Read More
公司最新訊息

你體內的「無名火」正在搞破壞!一招從源頭撲滅慢性發炎(淨火肽 Healtide® 機理大解密)

為什麼吃了消炎藥,身體的「火」還是滅不掉? 你是否經常遇到這樣的客戶反饋:消費者面對關節痠痛、過敏、腸胃不適或皮膚慢性暗沉,長期服用非類固醇消炎藥(NSAIDs)或塗抹類固醇,卻總是反覆發作、治標不治本 ?   現代醫學與功能生物學證實:90% 的慢性疾病與老化瓶頸,核心源頭都來自體內撲不滅的「慢性發炎」。 傳統生技產品或化學藥物的開發邏輯,大多著眼於抑制下游的 COX-1 或 COX-2 酵素 。用一個心智模型(Mental Model)來比喻:這就像火災發生時,你只是跑去「關掉煙霧探測器」,卻根本沒有沒收那個正在不斷點火的「打火機」! 長期下來,不僅無法根除發炎,化學藥物更可能增加肝腎與腸胃道的代謝負擔 。 市場正在尋找一種更高訊噪比、能「從源頭斷火」且安全無副作用的革命性生物素材。這正是富比積生物科技(AHB Lab)董事長莊國昇博士與研發團隊,成功推出第三代生物合成定序胜肽——淨火肽(Healtide®)的契機 。   淨火肽(Healtide®)的源頭阻斷機制 當人體受到刺激時,免疫系統的「巨噬細胞」會釋放 TNF-α(腫瘤壞死因子)與 IL-1β 等發炎細胞因子 。一旦失控,就會引發無差別攻擊正常組織的「細胞因子風暴」

Read More